Skip to main content

Advertisement

SpringerLink
Log in

Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Permanent interstitial brachytherapy represents the most conformal form of radiation therapy of the prostate and the number of patients with prostate cancers treated with permanent radioactive implants is increasing world wide. In the meanwhile long-term data on tumor control and treatment morbidity become available. Biochemical and clinical tumor control appears to be as effective as after radical prostatectomy or external beam radiation therapy in early prostate cancer. The risk of postreatment urinary incontinence and bowel dysfunction is low and erectile function can be preserved in the majority of patients. However, prostate brachytherapy requires a careful selection of patients as pretreatment factors predict for long-term outcome. The need for combined modality approaches in intermediate and high-risk patients remains controversely discussed. The continous refinement of intraoperative planning techniques and the elucidation of the etiology of urinary, sexual, and bowel dysfunction should result in further improvements in biochemical outcomes and decreased morbidity. Improved and standardized postimplantation evaluation will make outcome data more reliable and comparable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pasteau O (1911) Traitement du cancer de la prostate par le radium. Rev Mal Nutr 1911:363–367

    Google Scholar 

  2. Paschkis R (1911) Wien Klin Wochenschr 24:1562–1564

    Google Scholar 

  3. Barringer B (1917) Radium in the treatment of carcinoma of the bladder and prostate: review of 1y ear’s work. JAMA 68:1227–1230

    Google Scholar 

  4. Flocks RH, Kerr HD, Elkins HB, Culp DA (1954) The treatment of carcinoma of the prostate by interstitial radiation with radioactive gold (Au198): a follow-up report. J Urol 71:628–633

    PubMed  CAS  Google Scholar 

  5. Whitmore WF Jr, Hilaris B, Grabstald H (1972) Retropubic implantation of Iodine 125 in the treatment of prostate cancer. J Urol 108:918–920

    PubMed  Google Scholar 

  6. Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I (1983) Transperineal 125 Iodine seed implantation in prostatic cancer guided by transrectal ultrasoundsonography. J Urol 130:283–2861

    PubMed  CAS  Google Scholar 

  7. Ling CC (1992) Permanent implants using Au-198, Pd-103 and I-125: a radiobiological considerations based on the linear quadratic model. Int J Radiat Oncol Biol Phys 23:81–87

    PubMed  CAS  Google Scholar 

  8. Nath R, Anderson LL, Luxton G (1995) Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group o.43. American Association of Physicists in Medicine. Med Phys 22:209–234

    Article  PubMed  CAS  Google Scholar 

  9. Beyer D, Nath R, Buller W (2000) American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103) palladium brachytherapy. Int J Radiat Oncol Biol Phys 47:273–275

    Article  PubMed  CAS  Google Scholar 

  10. Williamson JF, Coursey BM, deWerd LA (2000) Recommendations of the American association of physicists in medicine on 103Pd interstitial source calibration and dosimetry: Implications for dose specification and prescription. Med Phys 27:634–642

    Article  PubMed  CAS  Google Scholar 

  11. Blasko JC, Wallner K, Grimm PD, Ragde H (1995) PSA-based disease control following ultrasound—guided 125J implantation for stage T1/T2 prostatic carcinoma. J Urol 154:1096–1099

    Article  PubMed  CAS  Google Scholar 

  12. Stock RG, Stone NN, Wesson MF, DeWyngaert JK (1995) A modified technique allowing interactive ultrasound – guided three – dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32:219–225

    PubMed  CAS  Google Scholar 

  13. Quimby EH (1932) The grouping of radium tubes in packs and plaques to produce the desired distribution of radiation. Am J Roentgenol 27:18–36

    Google Scholar 

  14. Paterson R, Parker HM (1943) A dosage system for gamma-ray therapy 1+2  . Br J Radiol 7:592–632

    Article  Google Scholar 

  15. Prete JJ, Prestidge BR, Bice WS, Friedland JL, Stock RG, Grimm PD (1998) A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys 40:1001–1008

    Article  PubMed  CAS  Google Scholar 

  16. Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y (2000) American brachytherapy guidelines for post-implant dosimetry for prostate brachytherapy. Int J Radiat Oncol Biol Phys 46:221–230

    Article  PubMed  CAS  Google Scholar 

  17. Stock RG, Stone NN (2002) Importance of post-implant dosimetry in permanent brachytherapy. Eur Urol 41:434–439

    Article  PubMed  Google Scholar 

  18. Waterman FM, Yue N, Corn BW, Dicker AP (1998) Edema associated with I-125 or PD-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 41:1069–1077

    PubMed  CAS  Google Scholar 

  19. Stock RG, Stone NN, Tabert A, Ianuzzi C, DeWyngaert JK (1998) A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41:101–108

    PubMed  CAS  Google Scholar 

  20. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L (2000) ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57:315–321

    Article  PubMed  CAS  Google Scholar 

  21. Wirth MP, Hermann T, Alken P, Kovacs G, Müller R-P, Hakenberg OW, Ahlemann L, Schalkhäuser K (2002) Empfehlungen zur Durchführung der alleinigen, permanenten, interstitiellen Brachytherapie beim lokal begrenzten Prostatakarzinom. Strahlenther Onkol 178:115–119

    PubMed  CAS  Google Scholar 

  22. Grimm PD, Blasko JC, Sylvester JE (2001) 10y ear biochemical (PSA) control of prostate cancer with Iodine-125 brachytherapy. Int J Radiat Biol Phys 51:31–40

    CAS  Google Scholar 

  23. Blasko JC, Grimm PD, Sylvester JE (2000) Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46:839–850

    PubMed  CAS  Google Scholar 

  24. Ragde H, Korb L, Elgamal AA (2000) A 12 year follow-up after transperineal brachytherapy of localized prostate cancer. J Urol 163(4, Suppl I):336–337

    Google Scholar 

  25. Brachman DG, Thomas T, Hilbe J, Beyer DC (2000) Failure-free survival following brachyherapy alone or external beam irridiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice. Int J Radiat Oncol Biol Phys 48:111–117

    Article  PubMed  CAS  Google Scholar 

  26. Grimm PD, Blasko JC, Sylvester JE (2001) 10y ear biochemical (PSA) control of prostate cancer with Iodine-125 brachytherapy. Int J Radiat Biol Phys 51:31–40

    CAS  Google Scholar 

  27. Beyer DC, Thomas T, Hilbe J, Swenson V (2003) Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer. Brachytherapy 2(2):77–84

    Article  PubMed  Google Scholar 

  28. Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, Reuther AM, Kupelian PA (2004) Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71(1):29–33

    Article  PubMed  Google Scholar 

  29. Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA (2004) Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation and combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer. Int J Radiat Oncol Biol Phys 58(1):25–33

    Article  PubMed  Google Scholar 

  30. Sylvester JE, Blasko JC, Grimm R, Meier R, Spiegel JF, Malmgren JA (2004) Fifteen year follow-up of the first cohort of localized prostate cancer patients treated with brachytherapy. J Clin Oncol 22(145):4567

    Google Scholar 

  31. Potters C, Morgenstern C, Calugaru E, Fearn P, Jassal A, Presser J, Mullen E (2005) 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173(5):1562–1566

    Article  PubMed  Google Scholar 

  32. Stone NN, Stock RG, Unger P (2005) Intermediate term biochemical-free progression andlocal control following 125 Iodine brachytherapy for prostate cancer. J Urol 173:803–807

    Article  PubMed  Google Scholar 

  33. Stone NN, Stock RG (1999) Prostate brachtherapy: Treatment strategies. J Urol 162:421–426

    Article  PubMed  CAS  Google Scholar 

  34. Sharkey J, Chovnick SD, Behar RD (2000) Minimally invasive treatment for localized adenocarcinoma of the prostate. Review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy. J Endourol 14:343–354

    Article  PubMed  CAS  Google Scholar 

  35. Potters L, Cha C, Oshinsky G (1999) Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy. Cancer J Sci Am 5:301–306

    PubMed  CAS  Google Scholar 

  36. Sylvester J, Blasko JC, Grimm PD (2000) Short-course androgen ablation combined with external-beam radiation therapy and low-dose rate permanent brachytherapy in early-stage prostate cancer: A matched subset analysis. Mol Urol 3:155–160

    Google Scholar 

  37. Blasko JC, Ragde H, Grimm PD (1997) Potential for neoadjuvant hormonal therapy with brachytherapy for prostate cancer. Mol Urol 1:207–214

    CAS  Google Scholar 

  38. Wallner K, Blasko JC, Dattoli MJ (2001) Prostate brachytherapy made complicated. 2nd edn. Smart-Medicine Press, Seattle, WA

    Google Scholar 

  39. Blasko JC, Grim PD, Sylvester JE (2000) The role of external beam radiotherapy with J-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol 57:273–278

    Article  PubMed  CAS  Google Scholar 

  40. Arterbery VE, Wallner K, Roy J, Fuks Z (1993) Short-term morbidity from CT-planned transperineal 125J prostate implants. Int J Radiat Oncol Biol Phys 25:661–665

    PubMed  CAS  Google Scholar 

  41. Zeitlin SI, Sherman J, Raboy A, Lederman G, Albert P (1998) High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol 91:91–94

    Google Scholar 

  42. Vijverberg PLM, Blank LECM, Dabhoiwala NF, deReijke TM, Koedooder C (1993) Analysis of biopsy findings and implant quality following ultrasonically – guided 125-J implantation for localized prostatic carcinoma. Br J Urol 72:470–477

    Article  PubMed  CAS  Google Scholar 

  43. Gelblum DY, Potters L, Ashley R, Waldbaum R, Wang XH, Leibel S (1999) Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45:59–64

    PubMed  CAS  Google Scholar 

  44. Merrick GS, Butler WM, Lief JH, Dorsey LT (2000) Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys 47:121–125

    PubMed  CAS  Google Scholar 

  45. Wallner KE, Roy J, Zelefsky M, Fuks Z, Harrison L (1995) Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal 125J prostate brachytherapy. Int J Radiat Oncol Biol Phys 32:465–471

    Article  PubMed  CAS  Google Scholar 

  46. Nag S, Scaperoth DD, Badalament R, Hall SA, Burgers J (1995) Transperineal palladium-103 prostate brachytherapy: analysis of morbidity and seed migration. Urology 45:87–92

    Article  PubMed  CAS  Google Scholar 

  47. Storey MR, Landgren RC, Cottone JL (1999) Transperineal iodine-125 implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. Int J Radiat Oncol Biol Phys 43:565–571

    PubMed  CAS  Google Scholar 

  48. Talcott JA, Clark JC, Stark P (1999) Long-term treatment-related complications of brachytherapy for early prostate cancer: A survey of treated patients. Proc Annu Meet Am Soc Clin Oncol 18:1196–1205

    Google Scholar 

  49. Stock RG, Stone NN, Dalal M (2000) Patient reported long-term urinary morbidity and quality of life following 125J prostate brachytherapy. J Urol 163(4, Suppl I):1268

    Google Scholar 

  50. Stone NN, Stock RG (2002) Complications following permanent prostate brachytherapy. Eur Urol 41(4):427–433

    Article  PubMed  CAS  Google Scholar 

  51. Gelblum DY, Potters L (2000) Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48(1):119–124

    Article  PubMed  CAS  Google Scholar 

  52. Snyder KM, Stock RG, Hong SM, LoYc, Stone NN (2001) Defining the risk of developing grade 2 proctitis following 125J prostate brachytherapy using a rectal dose volume histogram analysis. Int J Radiat Oncol Biol Phys 50:335–341

    Article  PubMed  CAS  Google Scholar 

  53. Merrick GS, Butler WM, Dorsey AT, Lief JH, Walbert HL, Blatt HJ (1999) Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys 43:1021–1027

    Article  PubMed  CAS  Google Scholar 

  54. Albert M, Tempany CM, Schultz D, Chen MH, Cormack RA, Kumar S (2003) Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 98(5):949–954

    Article  PubMed  Google Scholar 

  55. Kaye KW, Olson DJ, Payne JT (1995) Detailed preliminary analysis of 125 iodine implantation for localized prostate cancer using percutaneous approach. J Urol 153:1020–1025

    Article  PubMed  CAS  Google Scholar 

  56. Critz FA, Tarlton RS, Holladay DA (1995) Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. Cancer 75:2383–2391

    Article  PubMed  CAS  Google Scholar 

  57. Grado GL, Larson TR, Balch CS (1998) Actuarial disease-free survival after prostate brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys 42:289–298

    PubMed  CAS  Google Scholar 

  58. Zeitlin SI, Sherman J, Raboy A, Lederman G, Albert P (1998) High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol 160:91–95

    Article  PubMed  CAS  Google Scholar 

  59. Kao J, Stock RG, Stone NN (2000) Long-term erectile function following real-time ultrasound-guided brachytherapy for prostate cancer. J Urol 163(4, Suppl I):1276

    Google Scholar 

  60. Dattoli M, Wallner KE, Cash JC (1996) 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys 35:875–879

    PubMed  CAS  Google Scholar 

  61. Stock RG, Kao J, Stone NN (2001) Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 165:436–439

    Article  PubMed  CAS  Google Scholar 

  62. Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW (2001) Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 50(5):1235–1242

    PubMed  CAS  Google Scholar 

  63. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA (2005) Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 62(2):437–447

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Marien Krankenhaus Bergisch Gladbach gGmbH, Akademisches Lehrkrankenhaus der Universität Köln, Robert-Koch-Str.18, 51465, Bergisch Gladbach, Germany

    Stefan Machtens

  2. Department of Radiation Oncology, Hannover University Medical School, Hannover, Germany

    Rolf Baumann, Antje Warszawski, Andreas Meyer & Johann H. Karstens

  3. Department of Urology and Paediatric Urology, Hannover University Medical School, Hannover, Germany

    Jörn Hagemann & Udo Jonas

Authors
  1. Stefan Machtens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rolf Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jörn Hagemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antje Warszawski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johann H. Karstens
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Udo Jonas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Machtens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Machtens, S., Baumann, R., Hagemann, J. et al. Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer. World J Urol 24, 289–295 (2006). https://doi.org/10.1007/s00345-006-0083-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-006-0083-1

Keywords

Search

Navigation